Medication

A new study finds that the anti-inflammatory drug canakinumab (Ilaris) didn’t lower the risk of frailty in people with atherosclerosis.

One in five people who take nirmatrelvir/ritonavir (Paxlovid) get COVID-19 again after the drug clears them of it, according to a new study.

A new study finds that there was a higher rate of bleeding and not much of a difference in the efficacy when nursing home residents took standard doses of direct oral anticoagulants (DOACs) compared to...

Even though it may be more pricey for some people to get Paxlovid soon, a new study finds that taking it is linked to a small reduction in long COVID. The same is true for Lagevrio, the other oral drug...

A new study published Wednesday in JAMA Network Opens shows that stopping metformin is linked with increased dementia incidence. 

A combination of two medications can block the messages that cancer uses to hijack white blood cells in people who have treatment-resistant prostate cancer. The drugs shrank tumors or stopped their growth,...

New research suggests that a drug commonly used to treat hypertension is not dangerous, despite the concerns of some clinicians and researchers about potential health risks.   

Many older adults take anticoagulants to manage a variety of conditions. But new guidance on how to use them has caused some controversy because it changed some wording. It said certain medications should...

Use of antipsychotic and psychoactive drugs following surgery generally fell in various settings among those experiencing postoperative delirium, according to a study published in the Journal of the American...

A new drug called muvalaplin successfully lowers a genetic form of cholesterol that’s linked to higher risks of strokes and heart attacks, according to a new study published Monday in JAMA. It’s the...